UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2009, 1. Aufl., ISBN 1405155868, xxiii, 277
Gender Identity | Sexual Behavior | Women's Health | Acquired Immunodeficiency Syndrome | AIDS (Disease) | Preventive Health Services | prevention & control | Social aspects | Socioeconomic Factors | Africa, Southern | Acquired Immunodeficiency Syndrome - prevention & control - Africa South of the Sahara | HIV infections | Sexual behavior | AIDS (Disease) - Social aspects - Africa, Southern | Gay men | Gender Identity - Africa South of the Sahara | Medical anthropology | Social conditions
Book
2009, ISBN 0195328876, xiii, 368
Brain | Diagnostic Imaging | physiopathology | Imaging | methods | Aging | physiology | Geriatric neurology | Alzheimer's disease | Dementia | Neuroscientific Techniques | Development of the Nervous System | Vascular disease | Function | Dopamine | Mri | Prediction | Biochemistry | Diagnosis | Structure | Pet | Fmri
Book
CNS drugs, ISSN 1172-7047, 2008, Volume 22, Issue 3, pp. 213 - 237
Clonidine, adverse reactions | Attention deficit hyperactivity disorder, treatment | Atomoxetine, adverse reactions | Central nervous system stimulants, adverse reactions | Bupropion, adverse reactions | Alpha 2 adrenergic receptor agonists, adverse reactions | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Growth Disorders - chemically induced | Mental Disorders - epidemiology | Mental Disorders - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Growth Disorders - prevention & control | Mental Disorders - prevention & control | Clinical Trials as Topic | Attention Deficit Disorder with Hyperactivity - drug therapy | Antidepressive Agents - therapeutic use | Nervous System Diseases - epidemiology | Nervous System Diseases - prevention & control | Central Nervous System Stimulants - therapeutic use | Propylamines - therapeutic use | Central Nervous System Stimulants - adverse effects | Atomoxetine Hydrochloride | Growth Disorders - epidemiology | Cardiovascular Diseases - epidemiology | Nervous System Diseases - chemically induced | Cardiovascular Diseases - chemically induced | Antidepressive Agents - adverse effects | Propylamines - adverse effects | Anorexia | Hyperactivity | Complications | Attention deficit hyperactivity disorder | Clinical trials | FDA approval | Epidemiology | Cancer therapies | Carcinogenesis | Children & youth | Prescription drugs | Sleep disorders | Side effects | Stimulants | Insomnia | Cell cycle | Teenagers | Drug dosages | Seizures | Child & adolescent psychiatry | Index Medicus
Journal Article
Drug and alcohol review, ISSN 0959-5236, 01/2007, Volume 26, Issue 1, pp. 33 - 39
clinical management | treatment for drug addiction | prefrontal | MRI | addiction | impulsive behaviour | compulsive behaviour | inhibition | cingulate | drug dependence | neuropsychological | neuroimaging | Neuroimaging | Neuropsychological | Treatment for drug addiction | Clinical management | Addiction | Cingulate | Impulsive behaviour | Prefrontal | Drug dependence | Inhibition | Compulsive behaviour | Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Neurotoxicity Syndromes - diagnosis | Cognition Disorders - chemically induced | Humans | Prefrontal Cortex - physiopathology | Decision Making - drug effects | Neurotoxicity Syndromes - psychology | Prefrontal Cortex - drug effects | Gyrus Cinguli - drug effects | Mental Disorders - diagnosis | Substance-Related Disorders - diagnosis | Cognition Disorders - psychology | Inhibition (Psychology) | Cognition Disorders - physiopathology | Mental Disorders - chemically induced | Comorbidity | Substance-Related Disorders - physiopathology | Mental Disorders - physiopathology | Mental Disorders - psychology | Neuropsychological Tests | Cognition Disorders - diagnosis | Magnetic Resonance Imaging | Neurotoxicity Syndromes - physiopathology | Gyrus Cinguli - physiopathology | Substance-Related Disorders - psychology | Decision Making - physiology | Street Drugs - toxicity | Decision Making | Behavior, Addictive, psychology | Substance-Related Disorders, physiopathology | Behavior, Addictive, physiopathology | Brain, drug effects | Gyrus Cinguli, physiology | Substance-Related Disorders, psychology | Brain, growth and development | Opioid-Related Disorders, physiopathology | Prefrontal Cortex, physiology | Adolescent | Brain Mapping | Adult | Index Medicus
Journal Article
World journal of gastroenterology : WJG, ISSN 1007-9327, 2017, Volume 23, Issue 30, pp. 5486 - 5498
Microbiota | Dysbiosis | Braingut axis | Mental health | Microbiome | Psychiatric conditions | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Pituitary-Adrenal System - physiopathology | Neurodegenerative Diseases - etiology | Brain - physiopathology | Epigenesis, Genetic | Humans | Neurodegenerative Diseases - prevention & control | Gastrointestinal Microbiome - physiology | Brain - growth & development | Fecal Microbiota Transplantation | DNA Methylation | Animals | Neurodevelopmental Disorders - prevention & control | Hypothalamo-Hypophyseal System - physiopathology | Neurodevelopmental Disorders - etiology | Stress, Psychological - complications | Disease Models, Animal | Stress, Psychological - physiopathology | Index Medicus | Minireviews | Brain-gut axis
Journal Article
2007, Adolescent Mental Health Initiative, ISBN 0195306260, x, 514 p., [16] p. of plates
Book
Journal of child psychology and psychiatry, ISSN 0021-9630, 03/2013, Volume 54, Issue 3, pp. 227 - 246
ADHD | medication | adverse events | European | management | recommendations | Social Sciences | Life Sciences & Biomedicine | Psychology, Developmental | Psychiatry | Psychology | Science & Technology | Therapy | Behavior Disorders | Europe | Drug Therapy | Risk | Foreign Countries | Suicide | Substance Abuse | Patients | Scientific Research | Incidence | Guidelines | Physical Development | Outcomes of Treatment | Sleep | Attention Deficit Hyperactivity Disorder | Literature Reviews | Meta Analysis | Symptoms (Individual Disorders) | Eating Habits | Seizures | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer | Psychology. Psychoanalysis. Psychiatry | Attention deficit disorders. Hyperactivity | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Biological and medical sciences | Medical sciences | Neuropharmacology | Drug toxicity and drugs side effects treatment | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Child clinical studies | Sleep Wake Disorders - chemically induced | Tic Disorders - therapy | Cardiovascular Diseases - prevention & control | Humans | Suicide - prevention & control | Dextroamphetamine - adverse effects | Seizures - chemically induced | Heart Rate - drug effects | Lisdexamfetamine Dimesylate | Central Nervous System Stimulants - adverse effects | Guanfacine - adverse effects | Atomoxetine Hydrochloride | Blood Pressure - drug effects | Child | Methylphenidate - administration & dosage | Substance-Related Disorders - etiology | Growth Disorders - chemically induced | Body Size - drug effects | Psychoses, Substance-Induced | Sleep Wake Disorders - therapy | Clonidine - adverse effects | Treatment Outcome | Methylphenidate - adverse effects | Seizures - therapy | Substance-Related Disorders - therapy | Attention Deficit Disorder with Hyperactivity - drug therapy | Propylamines - administration & dosage | Adolescent | Tic Disorders - chemically induced | Cardiovascular Diseases - chemically induced | Propylamines - adverse effects | Side effects | Drug therapy | Children & youth | Best practice | Index Medicus
Journal Article
2008, ISBN 9789812706072, xx, 328
Book